Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 1.15 |   |
Earnings Per Share | -$0.87 |   |
Price To Sales Ratio | 3.8K |   |
Price To Book Ratio | 10.45 |   |
Price To Tangible Book Ratio | 10.52 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 135.6M |   |
Float (MRQ) | 96.35% |   |
Shares Outstanding (MRQ) | 43.1M |   |
Short Interest as a % of Float (MRQ) | 22.63% |   |
Shares Held By Institutions (MRQ) | 13.6M |   |
Margins | Industry Range | |
---|---|---|
Sales | $0.00 |   |
Gross Margin | N/A | |
Net Profit Margin | N/A | |
EBIT Margin | N/A | |
EBITDA Margin | N/A | |
Operating Margins | N/A |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 11.50 |   |
Quick Ratio (MRQ) | 10.99 |   |
Total Debt/Equity Ratio (MRQ) | 30.43 |   |
Debt/Common Equity Ratio (MRQ) | 30.43 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -75.54% |   |
Return on Assets | -94.95% |   |
Asset Turnover | 0.00 |   |
Receivables Turnover | 0.00 |   |
Inventory Turnover | 1.44 |   |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 5.75% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*CVM does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.51%